My main research interests are focused upon Lewy body disease. My studies (in particular neurohysiological studies based on EEG evaluation of Dementia with Lewy bodies specific features) have contributed to the drawing up of the last version of the globally used Consensus criteria for the clinical and pathological diagnosis and management of dementia with Lewy bodies (DLB) and related disorders. The quantitative EEG method developed by me allowed to identify a supportive biomarker for the diagnosis . This was the first time that EEG was defined as a biomarker for a neurodegenerative dementia. I published extensively in the field of Lewy body disease and neurodegenerative conditions. These studies range from clinical to neurophysiological to neuroimaging methods to assess phenomenology and pathophysiology of Lewy Body Disease. During my education I also learned and applied neurophysiological methods to study the mechanisms underlying neurodegeneration on a neuronal and tissue (slices from animal models of neurodegeneration) basis. This allowed me to reach a more open view of neurodegenerative diseases, ranging from cell to system. I am member of the Steering Committee of the European DLB study group; Program Chair of Lewy body Dementia (LBD)-Professional Interest Areas (PIA) (ISTAART-AAIC); Chair of the prodromal Lewy Body Dementia work group of the LBD-PIA; National Secretary of the Italian Society of Neurology-Dementia; National coordinator of the Italian DLB study group under the aegis of the Italian Society of Neurology-Dementia.